To assess the physiological and clinical relevance of our proposed regulatory mechanism between SRF and YAP/TAZ activity, we accessed a publicly available patient dataset, the prostate cancer transcriptomic atlas (http://www.thepcta.org) (You et al, 2016). This evidence concerns the gene YAP1 and prostate carcinoma.